RecallDepth
Class II Terminated

INFeD (Iron Dextran Injection USP) 100 mg elemental iron/2 ml (50 mg/mL), Rx Only, packaged in a) single dose vials, (NDC 52544-931-07), b) carton of 10 x 2 ml Single Dose Vials (NDC 52544-931-02) Distributed by: Actavis Pharma, Inc. Parsippany, NJ 07054, Manufactured by: Patheon Italia S.p.A. Ferentino, Italy 03013.

This recall has been terminated (originally issued March 7, 2018).

Company
Allergan
Recall Initiated
December 13, 2017
Posted
March 7, 2018
Recall Number
D-0545-2018
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
163,694 cartons
Firm Location
Madison, NJ, United States
Official Source
View on FDA website ↗

Reason for Recall

Failed Stability Specifications: Product stability testing results did not meet specifications for iron content.

Distribution

Product was distributed nationwide in the USA.

Lot / Code Info

Lot# 15W05A, Exp.FEB-2018; 16W02A, Exp. DEC 2018; 16W05A, Exp. JAN-2019; 16W13A, Exp. APR-2019; 16W15A, 16W16A, 16W17A, Exp. MAY 2019; 16W18A, Exp. JUN 2019; 16W20A, 16W22A, Exp. SEP 2019; 17W01A, 17W02A, Exp. DEC-2019; 17W04A, 17W05A, Exp. JAN 2020; 17W09A, Exp. MAR-2020; 17W11A, 17W13A, Exp. MAY 2020; 17W14A, 17W15A, Exp. JUN 2020

More recalls by Allergan

View all recalls by this company →

Other recent Class II Drug recalls